UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): June 2, 2011

 


 

CALIPER LIFE SCIENCES, INC.

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware

 

001-32976

 

33-0675808

(State or other jurisdiction of
incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

68 Elm Street, Hopkinton, Massachusetts

 

01748

(Address of Principal Executive Offices)

 

(Zip Code)

 

(508) 435-9500

(Registrant’s telephone number, including area code)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On June 2, 2011, Caliper Life Sciences, Inc. held its Annual Meeting of Shareholders at its offices in Hopkinton, Massachusetts. As of April 15, 2011, the record date for the meeting, the Company had 52,479,178 shares of common stock issued and outstanding and entitled to vote at the meeting. Of these shares, 49,318,792 were present in person or represented by proxy at the meeting, which constituted a quorum for the transaction of business at the meeting. At the meeting, the Company’s shareholders voted:

 

1.               To elect one director to hold office until the 2014 Annual Meeting of Stockholders.

 

 

 

No. of Shares

 

 

 

 

 

 

 

 

 

Broker

 

 

 

For

 

Withheld

 

Abstain

 

Non-vote

 

Allan L. Comstock

 

43,223,908

 

654,552

 

0

 

5,440,332

 

 

2.               To ratify the selection by the Audit Committee of the Board of Directors, of Ernst & Young LLP as independent auditors of Caliper for its fiscal year ending December 31, 2011.

 

No. of Shares

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-vote

 

48,930,378

 

349,678

 

38,736

 

0

 

 

3.               To approve the 2011 Employee Stock Purchase Plan.

 

No. of Shares

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-vote

 

42,983,779

 

382,384

 

512,297

 

5,440,332

 

 

4.               To vote in an advisory capacity on the compensation of Caliper’s named executive officers.

 

No. of Shares

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-vote

 

41,388,221

 

2,415,588

 

74,651

 

5,440,332

 

 

5.               To vote in an advisory capacity on the frequency of holding advisory votes on the compensation of Caliper’s named executive officers.

 

No. of Shares

 

 

 

 

 

 

 

 

 

Broker

 

1 Year

 

2 Years

 

3 Years

 

Abstain

 

Non-vote

 

15,101,507

 

25,913,799

 

2,633,655

 

229,499

 

5,440,332

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

CALIPER LIFE SCIENCES, INC.

 

 

June 3, 2011

By:

/s/ Peter F. McAree

 

 

 

 

 

Peter F. McAree

 

 

Senior Vice President and CFO

 

3